Seven Indian pharma companies among the 20 sued by the US
44 US states, 20 drug companies, Teva Pharmaceuticals, Aurobindo Pharma, Lupin Wockhardt, Zydus Pharma, Dr Reddy’s Laboratories,…
Author
CPhI expert forecasts ‘huge growth in Middle East manufacturing with Europe a medium-term target’
Market looks well set for regional boom as second CPhI Middle East & Africa launches in Dubai: Madhukar Tanna, Chief Executive…
IQVIA launches MedTech dedicated to medical device and diagnostics industry
IQVIA MedTech provides innovative technology, focused solutions and consulting services to meet the industry-specific needs of…
Glenmark Pharmaceuticals receives ANDA approval for Esomeprazole Magnesium Delayed-Release Capsules
The drug is a generic version of Nexium Delayed-Release Capsules, 20 mg and 40 mg, of AstraZeneca Pharmaceuticals LP
Regulations for pharma ingredients in India – Too much hope from a complex market in 2019
Active Pharmaceutical Ingredient production in India, though a rapidly expanding industry, still faces a lot of competition form…
UK MHRA’s approval for Wockhardt’s manufacturing facilities continue
The approval was sanctioned for the company's Bhimpore, Kadaiya plants in Daman
P&G announces first quarter financial results
The company has reported a 17 per cent spike in sales from operations for the first quarter
Strides posts revenues worth Rs 8,389 million in Q4FY19
Board recommends dividend of Rs 3 per equity share of face value of Rs 10
Lupin launches generic seizure drug in US
The company has launched Clobazam tablets in the strengths of 10 mg and 20 mg, after having received an approval from the United…
Granules India’s total income for FY’19 up by 35 per cent
The company’s consolidated total income for the fourth quarter of FY’19 was Rs 615 crores -- an increase of 20 per cent from the…